Xu et al. (2026)
- Authors: Huimin Xu, Qiaoqi Li, Yingzhe Luo, Hong Zhu
- Institutes: Chengdu University of Traditional Chinese Medicine, Chengdu, China
- Publisher: Journal of Translational Medicine
- Link: DOI
Summary
This research introduces a novel ‘immune-vascular-cognitive axis’ framework to explain how peripheral immune signals interact with the brain’s internal environment to produce cognitive dysfunction. By characterizing ‘brain fog’ as a state of persistent but potentially modifiable neuroimmune dysregulation rather than permanent damage, it identifies specific cellular targets for future therapeutic development.
What was researched?
The study investigated the central nervous system processes, specifically the neurovascular and synaptic microenvironments, that link systemic immune disturbances to cognitive impairment in ME/CFS. It sought to integrate findings from neuroimaging and neurobiology into a cell-resolved framework for understanding cognitive symptoms.
Why was it researched?
Despite well-documented immune abnormalities in ME/CFS patients, the exact mechanisms by which these peripheral changes cause cognitive ‘brain fog’ remain poorly defined. This lack of mechanistic clarity has previously limited the ability to develop targeted treatments and stratify patients based on their biological profile.
How was it researched?
Researchers synthesized evidence from neuroimaging, neuroimmunology, neurovascular biology, and cellular metabolism to propose a brain-centered model. The review analyzed interactions among brain-resident cellular populations, such as microglia and astrocytes, within their local neurovascular unit.
What has been found?
The study identified microglial priming, astrocytic dysfunction, and excitation-inhibition imbalance as key processes associated with cognitive symptoms. Crucially, the findings suggest that cognitive dysfunction in ME/CFS reflects a state of persistent neuroimmune and neurometabolic dysregulation that may be reversible.
Discussion
A limitation of current research is the reliance on cross-sectional human studies, which demonstrate associations rather than direct causality. While evidence for neurovascular and glial alterations is relatively consistent, other proposed mechanisms like extracellular vesicle-mediated signaling and oligodendrocyte involvement remain more speculative.
Conclusion & Future Work
The review concludes that cognitive dysfunction in ME/CFS is a result of dynamic cellular interactions that could be targeted therapeutically. Proposed strategies for future investigation include cytokine blockade 💊, nitric oxide 💊 enhancement, and acupuncture to restore neurovascular and synaptic health.